Keflex and Low turnover osteopathy - a phase IV clinical study of FDA data

Summary:

Low turnover osteopathy is reported as a side effect among people who take Keflex (cephalexin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Fosamax, and have Osteoporosis.

The phase IV clinical study analyzes which people have Low turnover osteopathy when taking Keflex. It is created by eHealthMe based on reports of 14,902 people who have side effects when taking Keflex from the FDA, and is updated regularly.

What is Keflex?

Keflex has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 15,844 Keflex users. Check the latest studies of Keflex.

What is Low turnover osteopathy?

Low turnover osteopathy (slow removal of old bone and its replacement by new bone) is found to be associated with 402 drugs and 566 conditions by eHealthMe. Check the latest studies of Low turnover osteopathy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

14,902 people reported to have side effects when taking Keflex.
Among them, 14 people (0.09%) have Low turnover osteopathy.

Could Keflex cause Low turnover osteopathy?

Among these 14 people:

How long have people been on Keflex when they have Low turnover osteopathy? *

What is the gender of people who have Low turnover osteopathy when taking Keflex? *

female: 100 %
male: 0.0 %

What is the age of people who have Low turnover osteopathy when taking Keflex? *

What are other drugs people take besides Keflex? *

What are other side effects people have besides Low turnover osteopathy? *

High Blood Pressure: 14 people, 100.00%
Fatigue (feeling of tiredness): 14 people, 100.00%
Femur Fracture: 14 people, 100.00%
Stress And Anxiety: 14 people, 100.00%
High Blood Cholesterol: 12 people, 85.71%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 12 people, 85.71%
Hyperlipidaemia (presence of excess lipids in the blood): 11 people, 78.57%
Hypokalemia (low potassium): 11 people, 78.57%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 11 people, 78.57%
Fall: 10 people, 71.43%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 12 people, 85.71%
Osteopenia (a condition where bone mineral density is lower than normal): 11 people, 78.57%
Hypersensitivity: 2 people, 14.29%
Immunodeficiency Common Variable: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Keflex and have Low turnover osteopathy?

- Check whether Low turnover osteopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Keflex:

Keflex (15,844 reports)

Browse all side effects of Keflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Low turnover osteopathy:

Low turnover osteopathy (402 drugs)

Browse all the conditions that are associated with Low turnover osteopathy:

Low turnover osteopathy (566 conditions)

Related publications that referenced our studies

Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .
Agrawal A, Rao M, Jasdanwala S, Mathur A, Eng M, "Cephalexin Induced Cholestatic Jaundice", Case reports in gastrointestinal medicine, 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on cephalexin (the active ingredients of Keflex) and Keflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.